IDI1P1

Across TCGA pan-cancer cohorts, IDI1P1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated IDI1P1 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher IDI1P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated IDI1P1 expression acts as an unfavorable survival marker, although some lineages such as LUSC and KIRC show a favorable association.

LUSC, UCS, and CESC are the cancer types where IDI1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.609	0.346	<.001	72	view →
UCS	DFS	Tertile	All	0.085	0.312	.001	66	view →
CESC	DFS	Tertile	II,III,IV	0.656	0.807	.018	36	view →
KIRC	DFS	Tertile	II,III,IV	0.962	0.712	.013	36	view →
PAAD	OS	Tertile	All	0.217	0.483	.007	36	view →
LUAD	DFS	Tertile	All	0.808	0.633	.011	30	view →
KIRP	OS	Tertile	All	0.399	0.738	.007	27	view →
KICH	OS	Tertile	II,III,IV	0.468	0.927	.026	24	view →
READ	DFS	Tertile	III,IV	0.884	0.667	.010	13	view →
DLBC	OS	Tertile	All	0.372	0.861	.021	12	view →
UVM	DFS	Tertile	III,IV	0.189	0.685	.037	9	view →
HNSC	DFS	Tertile	III,IV	0.437	0.647	.030	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

IDI1P1–LUSC (OS)

Open the LUSC breakdown →